Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome

Project to Promote the Evaluation of the Cardiovascular Risk in the Clinical Practice and to Evaluate Its Evolution Following the Implementation of a Preventive Multifactorial Strategy Aimed to Reduce the Total Risk Level (SCORE Algorithm), in Subjects Suffering From Metabolic Syndrome and With a Risk Level ≥5%

This study will evaluate the efficacy of a multi factorial preventive scheme of action (including fluvastatin and valsartan) to reduce the overall risk level in patients with metabolic syndrome.

Inclusion Criteria:

• Age between 40 - 65 years
• Diagnosed metabolic syndrome
• Risk of cardiovascular death ≥ 5% (according to SCORE)
• Written informed consent

Exclusion Criteria:

• Women not in menopause or not using efficient contraception
• Known hypersensitivity to study drugs
• History of ischemic heart disease